Dr. Menard is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 857-307-1920Fax+1 857-307-1922
Education & Training
- Brigham and Women's HospitalFellowship, Vascular Surgery, 2001 - 2003
- Massachusetts General HospitalResidency, Surgery, 1994 - 2001
- Harvard Medical SchoolClass of 1994
Certifications & Licensure
- ME State Medical License Current
- MA State Medical License 1997 - 2026
- RI State Medical License 2022 - 2026
- CT State Medical License 2023 - 2025
- AZ State Medical License 2002 - 2004
- American Board of Surgery Vascular Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Open Versus Endovascular Repair of Popliteal Artery Aneurysm Trial Start of enrollment: 2013 Feb 01
- Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia Start of enrollment: 2014 Aug 01
Publications & Presentations
PubMed
- Advanced WIfI Stage is Associated with Poor Outcomes in the BEST-CLI Trial.Jeffrey J Siracuse, Alik Farber, Matthew T Menard, Kenneth Rosenfield, Michael S Conte
Journal of Vascular Surgery. 2024-12-03 - The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial.Matthew T Menard, Alik Farber, Gheorghe Doros, Katherine L McGinigle, Emiliano Chisci
Journal of Vascular Surgery. 2024-12-01 - Editor's Choice - Reduction of Major Amputations after Surgery versus Endovascular Intervention: The BEST-CLI Randomised Trial.Maarit A Venermo, Alik Farber, Andres Schanzer, Matthew T Menard, Kenneth Rosenfield
European Journal of Vascular and Endovascular Surgery. 2024-11-01
Press Mentions
- Amputations Still Avoided with Flow-Diverting Therapy for CLTI at 2 Years: PROMISE IINovember 6th, 2024
- BEST-CLI Shows Lower Incidence of Major Adverse Limb Events or Death with Surgical Bypass Versus Endovascular Treatment in CLTI Patients with Adequate GSVJanuary 23rd, 2023
- Restored Blood Flow Reduces Pain and Increases QoL in Patients with PADNovember 9th, 2022
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: